BENDAMUSTINE GEN bendamustine hydrochloride 25 mg powder for injection vial

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

bendamustine hydrochloride, Quantity: 25 mg

Tilgængelig fra:

Luminarie Pty Ltd

Lægemiddelform:

Injection, powder for

Sammensætning:

Excipient Ingredients: mannitol

Indgivelsesvej:

Intravenous, Intravenous Infusion

Enheder i pakken:

1 vial

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C). Efficacy relative to first-line therapies other than chlorambucil has not been established.,Previously untreated indolent CD20-positive, stage III-IV Non-Hodgkin?s lymphoma, in combination with rituximab.,Previously untreated CD20-positive, stage III-IV Mantle Cell Lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,Relapsed/Refractory indolent Non-Hodgkin?s lymphoma.

Produkt oversigt:

Visual Identification: white to off-white sterile lyophilized powder; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Autorisation status:

Registered

Autorisation dato:

2020-09-23